| 2X0W | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | X0W, ZN | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant., Basse N, Kaar JL, Settanni G, Joerger AC, Rutherford TJ, Fersht AR, Chem Biol. 2010 Jan 29;17(1):46-56. PMID:20142040 | ||||||||||||||
| Data retrieval |
![]() |
| View 2X0W in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
according to TCDB. |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |